应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
JNJ 强生
交易中 12-15 10:43:58 EST
213.66
+2.08
+0.98%
最高
214.26
最低
209.01
成交量
217.09万
今开
210.35
昨收
211.58
日振幅
2.48%
总市值
5,148亿
流通市值
5,138亿
总股本
24.09亿
成交额
4.62亿
换手率
0.09%
流通股本
24.05亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
FDA授予Teclistamab与Daratumumab联合用于复发/难治性多发性骨髓瘤国家优先奖券
美股速递 · 20分钟前
FDA授予Teclistamab与Daratumumab联合用于复发/难治性多发性骨髓瘤国家优先奖券
新闻稿：海恩时富任命艾莉森·E·刘易斯为总裁兼首席执行官
投资观察 · 20:03
新闻稿：海恩时富任命艾莉森·E·刘易斯为总裁兼首席执行官
美国FDA批准Akeega®作为首款针对BRCA2突变的转移性去势敏感性前列腺癌的精准疗法，疾病进展较标准疗法降低54%
美股速递 · 12-13 09:26
美国FDA批准Akeega®作为首款针对BRCA2突变的转移性去势敏感性前列腺癌的精准疗法，疾病进展较标准疗法降低54%
加州陪审团裁定强生公司需支付4000万美元，因未警告消费者婴儿爽身粉致癌风险
美股速递 · 12-13 08:53
加州陪审团裁定强生公司需支付4000万美元，因未警告消费者婴儿爽身粉致癌风险
FDA批准Niraparib和Abiraterone Acetate联合泼尼松用于BRCA2突变的转移性去势敏感性前列腺癌
美股速递 · 12-13 05:20
FDA批准Niraparib和Abiraterone Acetate联合泼尼松用于BRCA2突变的转移性去势敏感性前列腺癌
欧洲药品管理局推荐扩展Arexvy、Aspaveli、Dovprela、Elucirem、Eylea、Nucala、Recarbrio、Simponi、Uplizna、Vueway的适应症
美股速递 · 12-12
欧洲药品管理局推荐扩展Arexvy、Aspaveli、Dovprela、Elucirem、Eylea、Nucala、Recarbrio、Simponi、Uplizna、Vueway的适应症
花旗上调强生目标价至232美元
格隆汇 · 12-12
花旗上调强生目标价至232美元
强生多发性骨髓瘤联合疗法取得“显著”成果
环球市场播报 · 12-10
强生多发性骨髓瘤联合疗法取得“显著”成果
阶段 III Majestec-3 研究的前所未有结果支持 Tecvayli® 联合 Darzalex Faspro® 作为复发/难治性多发性骨髓瘤患者的潜在第二线标准治疗
美股速递 · 12-09
阶段 III Majestec-3 研究的前所未有结果支持 Tecvayli® 联合 Darzalex Faspro® 作为复发/难治性多发性骨髓瘤患者的潜在第二线标准治疗
礼来(LLY.US)、强生(JNJ.US)与辉瑞(PFE.US)拓展中国市场：旗下创新药物纳入首版商保目录
智通财经 · 12-08
礼来(LLY.US)、强生(JNJ.US)与辉瑞(PFE.US)拓展中国市场：旗下创新药物纳入首版商保目录
2025国谈落地：双管齐下 从“用得上”走向“用得起”
21世纪经济报道 · 12-08
2025国谈落地：双管齐下 从“用得上”走向“用得起”
AI制药，炒作还是革命？权威媒体：调查400位业内人士，发现了行业真相
智药局 · 12-06
AI制药，炒作还是革命？权威媒体：调查400位业内人士，发现了行业真相
2026年1月1日起，强生将迎来重大重组！
药智医械 · 12-06
2026年1月1日起，强生将迎来重大重组！
巴克莱上调强生目标价至197美元
格隆汇 · 12-03
巴克莱上调强生目标价至197美元
阿尔茨海默病研发不易，诺和诺德、强生新药试验接连失败！
制药网 · 12-02
阿尔茨海默病研发不易，诺和诺德、强生新药试验接连失败！
创新高！华尔街看涨情绪浓厚 强生(JNJ.US)市值首破5000亿美元
智通财经 · 11-27
创新高！华尔街看涨情绪浓厚 强生(JNJ.US)市值首破5000亿美元
2025年，药企已达成4起超百亿元收购！
制药网 · 11-25
2025年，药企已达成4起超百亿元收购！
强生(JNJ.US)first-in-class新药在国内申报上市 CDE将其纳入拟优先审评
智通财经 · 11-20
强生(JNJ.US)first-in-class新药在国内申报上市 CDE将其纳入拟优先审评
FDA给予Daratumumab和Hyaluronidase-Fihj传统批准，用于新诊断的轻链淀粉样变病
美股速递 · 11-20
FDA给予Daratumumab和Hyaluronidase-Fihj传统批准，用于新诊断的轻链淀粉样变病
强生表示FDA批准Caplyta作为辅助抑郁症治疗药物
投资观察 · 11-20
强生表示FDA批准Caplyta作为辅助抑郁症治疗药物
公司概况
公司名称：
强生
所属市场：
NYSE
上市日期：
--
主营业务：
强生公司于1887年在新泽西州注册成立。强生公司及其子公司从事医疗保健领域各种产品的研发、制造和销售。强生公司是一家控股公司，旗下运营公司几乎遍布全球所有国家。公司的主要重点是与人类健康和福祉相关的产品。公司分为两个业务部门：创新医学和医疗技术。
发行价格：
--
{"stockData":{"symbol":"JNJ","market":"US","secType":"STK","nameCN":"强生","latestPrice":213.66,"timestamp":1765813438317,"preClose":211.58,"halted":0,"volume":2170889,"delay":0,"floatShares":2404573193,"shares":2409295102,"eps":10.347906,"marketStatus":"交易中","change":2.08,"latestTime":"12-15 10:43:58 EST","open":210.345,"high":214.26,"low":209.0057,"amount":462159234.96770996,"amplitude":0.024834,"askPrice":213.67,"askSize":35,"bidPrice":213.63,"bidSize":10,"shortable":3,"etf":0,"ttmEps":10.347906,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1765832400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":-797371200000,"exchange":"NYSE","adjPreClose":211.58,"dividendRate":0.023776,"preHourTrading":{"tag":"盘前","latestPrice":209.84,"preClose":211.58,"latestTime":"09:29 EST","volume":56033,"amount":11856949.81615,"timestamp":1765808999915},"postHourTrading":{"tag":"盘后","latestPrice":211.7199,"preClose":211.58,"latestTime":"19:59 EST","volume":520927,"amount":110203197.835399,"timestamp":1765587599399},"volumeRatio":1.335751,"optionData":{"bulkOrders":[{"symbol":"JNJ","call":true,"expireDate":1768539600000,"strike":"210.0","timestamp":1765812890729,"price":7.66,"volume":1450,"amount":1110700,"type":"-"}]},"impliedVol":0.2353,"impliedVolPercentile":0.848},"requestUrl":"/m/hq/s/JNJ/wiki","defaultTab":"wiki","newsList":[{"id":"1194148525","title":"FDA授予Teclistamab与Daratumumab联合用于复发/难治性多发性骨髓瘤国家优先奖券","url":"https://stock-news.laohu8.com/highlight/detail?id=1194148525","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194148525?lang=zh_cn&edition=full","pubTime":"2025-12-15 23:24","pubTimestamp":1765812252,"startTime":"0","endTime":"0","summary":"FDA授予Teclistamab与Daratumumab联合用于复发/难治性多发性骨髓瘤国家优先奖券","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1267930813.SGD","LU1430594728.SGD","IE00BLSP4239.USD","LU2471134952.CNY","IE0002141913.USD","IE00BDGV0183.EUR","IE0009355771.USD","LU0203347892.USD","LU0466842654.USD","LU1074936037.SGD","BK4592","IE00BSNM7G36.USD","IE00BVYPNV92.GBP","IE00B2B36J28.USD","IE00BLSP4452.SGD","LU0345770993.USD","LU1244550577.SGD","LU2468319806.SGD","LU0058720904.USD","LU0122379950.USD","IE000M9KFDE8.USD","BK4559","LU2750360641.GBP","LU0289739699.SGD","LU2471134523.USD","IE00BFTCPJ56.SGD","LU0345770308.USD","IE00B42XCP33.USD","IE00B1BXHZ80.USD","LU1244550221.USD","LU1221951046.USD","LU0070217475.USD","IE00BGHQF631.EUR","LU0795875169.SGD","LU2430703178.SGD","LU1496350502.SGD","IE00B3T34201.USD","LU1066051498.USD","LU2750360997.AUD","LU0795875086.SGD","LU1162221912.USD","LU0098860793.USD","IE00BJT1NW94.SGD","LU1506573853.SGD","LU0889566641.SGD","BK4532","LU2471134879.HKD","LU2133065610.SGD","LU0787776722.HKD","LU1032955483.USD","BK4504","LU1196500208.SGD","LU1935042991.SGD","BK4585","IE00BKVL7J92.USD","LU1674673691.USD","IE0002270589.USD","JNJ","IE00B7SZLL34.SGD","LU1221951129.SGD","LU2602419157.SGD","LU2471134796.USD","BK4588","LU1732799900.SGD","LU2112291526.USD","LU1057294990.SGD","LU1066051225.USD","LU1023059063.AUD","LU1732800096.USD","SG9999001440.SGD","LU1066051811.HKD","LU0985320562.USD","LU2430703095.HKD","LU1914381329.SGD","LU1261432733.SGD","IE00B19Z3B42.SGD","LU2505996509.AUD","LU2129689605.HKD","LU0683600562.USD","LU1718418525.SGD","LU2347655156.SGD","SG9999002224.SGD","LU0345769128.USD","LU1244550494.USD","IE00BFXG1179.USD","LU2089984988.USD","IE00BN8TJ469.HKD","LU2430703251.USD","BK4568","LU2129689431.USD","LU0792757196.USD","LU1778281490.HKD","LU0320765646.SGD","IE00BVYPNW00.USD","BK4550","LU1894683348.USD","LU1066053197.SGD","LU0345769631.USD","LU0124676726.USD","BK4581","LU0203345920.USD","IE00B3PB1722.GBP","IE00BZ1G4Q59.USD","BK4534","LU1032466523.USD","SG9999002232.USD","LU0432979614.USD","LU0689626769.HKD","LU0234570918.USD","IE00BBT3K403.USD","IE00B19Z3581.USD","LU2592432038.USD","BK4007","LU0640476718.USD","LU1585245621.USD","LU1894683264.USD","LU1280957306.USD","IE00BJJMRZ35.SGD","LU1061106388.HKD","LU2129689514.USD","LU1929549753.HKD","IE00B4R5TH58.HKD","LU0912757837.SGD","LU0234572021.USD","LU0114720955.EUR","LU1059921491.USD","BK4533","LU1674673428.USD","LU2505996681.GBP","LU0882574055.USD","IE0034235303.USD"],"gpt_icon":0},{"id":"1174478372","title":"新闻稿：海恩时富任命艾莉森·E·刘易斯为总裁兼首席执行官","url":"https://stock-news.laohu8.com/highlight/detail?id=1174478372","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174478372?lang=zh_cn&edition=full","pubTime":"2025-12-15 20:03","pubTimestamp":1765800214,"startTime":"0","endTime":"0","summary":"新泽西州霍博肯，2025年12月15日——海恩时富集团今日宣布，艾莉森·E·刘易斯已被任命为总裁兼首席执行官，立即生效。刘易斯女士自2025年5月以来一直担任海恩时富的代理总裁兼首席执行官。刘易斯女士还将继续担任董事会成员。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3B42.SGD","LU0889566641.SGD","LU1074936037.SGD","LU2471134879.HKD","LU2129689605.HKD","LU2468319806.SGD","BK4504","LU1032466523.USD","BK4585","IE00BJT1NW94.SGD","LU1718418525.SGD","LU2430703178.SGD","BK4532","LU1261432733.SGD","LU1496350502.SGD","LU1066051225.USD","IE00BDGV0183.EUR","BK4212","LU1196500208.SGD","LU1506573853.SGD","LU1066051811.HKD","LU2471134796.USD","LU1162221912.USD","BK4581","LU1244550221.USD","LU1674673691.USD","LU0289739699.SGD","LU2505996509.AUD","LU1732799900.SGD","BK4604","SG9999002224.SGD","LU1221951046.USD","LU1732800096.USD","LU0345769128.USD","BK4592","LU1778281490.HKD","LU0098860793.USD","IE0002141913.USD","IE00B2B36J28.USD","IE00BVYPNW00.USD","LU0912757837.SGD","IE00B3T34201.USD","IE000M9KFDE8.USD","LU0689626769.HKD","IE00B19Z3581.USD","BK4559","LU0683600562.USD","LU1430594728.SGD","LU0345770993.USD","LU0320765646.SGD","IE00BZ1G4Q59.USD","LU0114720955.EUR","LU2129689514.USD","LU0203345920.USD","LU1244550577.SGD","LU2602419157.SGD","LU0787776722.HKD","LU1059921491.USD","IE00BSNM7G36.USD","LU1894683264.USD","LU2430703095.HKD","LU2505996681.GBP","BK4022","IE00B42XCP33.USD","IE00BLSP4452.SGD","LU2471134523.USD","IE00BFTCPJ56.SGD","TM","IE00B7SZLL34.SGD","IE00B4R5TH58.HKD","LU0070217475.USD","LU1894683348.USD","LU1935042991.SGD","SG9999001440.SGD","LU1023059063.AUD","LU0234570918.USD","IE00BN8TJ469.HKD","IE00B1BXHZ80.USD","BK4561","LU2430703251.USD","LU2592432038.USD","IE00BBT3K403.USD","LU1280957306.USD","LU0234572021.USD","BK4550","LU1244550494.USD","IE00BFXG1179.USD","BK4232","LU2089984988.USD","BK4007","LU0792757196.USD","LU1267930813.SGD","R","LU0432979614.USD","LU1914381329.SGD","LU1066053197.SGD","LU0345769631.USD","LU0124676726.USD","LU0795875169.SGD","IE00BGHQF631.EUR","LU0203347892.USD","BK4568","LU1061106388.HKD","LU0058720904.USD","LU0795875086.SGD","IE00BVYPNV92.GBP","LU1929549753.HKD","BK4555","LU1585245621.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU1057294990.SGD","LU2133065610.SGD","LU0985320562.USD","LU0122379950.USD","BK4588","LU1674673428.USD","BK4099","HAIN","IE00B3PB1722.GBP","IE00BKVL7J92.USD","LU2129689431.USD","IE0034235303.USD","IE0002270589.USD","BK4534","IE00BLSP4239.USD","LU1066051498.USD","BK4533","LU1032955483.USD","SG9999002232.USD","LU1221951129.SGD","JNJ","LU2112291526.USD","LU0345770308.USD","LU0882574055.USD","LU2750360641.GBP","LU2471134952.CNY","LU2347655156.SGD","LU2750360997.AUD","LU0640476718.USD","03160","LU0466842654.USD"],"gpt_icon":0},{"id":"1147087019","title":"美国FDA批准Akeega®作为首款针对BRCA2突变的转移性去势敏感性前列腺癌的精准疗法，疾病进展较标准疗法降低54%","url":"https://stock-news.laohu8.com/highlight/detail?id=1147087019","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147087019?lang=zh_cn&edition=full","pubTime":"2025-12-13 09:26","pubTimestamp":1765589196,"startTime":"0","endTime":"0","summary":"美国FDA批准Akeega®作为首款针对BRCA2突变的转移性去势敏感性前列腺癌的精准疗法，疾病进展较标准疗法降低54%","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0070217475.USD","LU0795875169.SGD","LU0912757837.SGD","LU1032955483.USD","BK4007","BK4588","IE00BLSP4239.USD","LU1267930813.SGD","BK4592","LU2347655156.SGD","LU1057294990.SGD","IE00BBT3K403.USD","LU2430703251.USD","LU0345770993.USD","IE0009355771.USD","LU2471134879.HKD","LU1935042991.SGD","LU1914381329.SGD","LU2471134952.CNY","IE00B3PB1722.GBP","LU2089984988.USD","LU1061106388.HKD","LU2505996509.AUD","LU2468319806.SGD","LU1023059063.AUD","LU0345769631.USD","LU0985320562.USD","IE00B1BXHZ80.USD","LU0098860793.USD","LU0289739699.SGD","IE00BZ1G4Q59.USD","LU1430594728.SGD","LU2430703178.SGD","BK4532","IE00B19Z3581.USD","LU2129689431.USD","LU1674673428.USD","IE00BJT1NW94.SGD","IE00BDGV0183.EUR","JNJ","LU2129689514.USD","LU0889566641.SGD","IE000M9KFDE8.USD","LU0114720955.EUR","IE00BN8TJ469.HKD","LU0787776722.HKD","LU1674673691.USD","LU0203347892.USD","IE00BLSP4452.SGD","IE00BVYPNV92.GBP","LU0432979614.USD","LU0203345920.USD","IE00BVYPNW00.USD","LU0234570918.USD","SG9999002232.USD","IE00B2B36J28.USD","LU1066053197.SGD","LU1894683348.USD","BK4533","LU0640476718.USD","LU1032466523.USD","LU2129689605.HKD","BK4568","SG9999002224.SGD","LU1732799900.SGD","LU0466842654.USD","LU1221951046.USD","IE00B7SZLL34.SGD","BK4550","LU2133065610.SGD","IE0002270589.USD","IE00BFTCPJ56.SGD","LU0124676726.USD","BK4581","LU0882574055.USD","IE00B42XCP33.USD","LU1261432733.SGD","LU1244550221.USD","LU1894683264.USD","IE00BJJMRZ35.SGD","LU1496350502.SGD","IE00BKVL7J92.USD","LU0058720904.USD","LU2471134523.USD","BK4585","LU1280957306.USD","LU0122379950.USD","LU2750360997.AUD","LU0345770308.USD","LU1929549753.HKD","LU1732800096.USD","LU1778281490.HKD","IE00B3T34201.USD","LU0689626769.HKD","LU1506573853.SGD","LU2112291526.USD","BK4559","SG9999001440.SGD","LU1162221912.USD","IE0034235303.USD","IE00BFXG1179.USD","LU2471134796.USD","LU0792757196.USD","IE0002141913.USD","LU0234572021.USD","LU1066051498.USD","LU1059921491.USD","BK4504","LU1196500208.SGD","LU1244550577.SGD","LU1221951129.SGD","IE00B19Z3B42.SGD","LU1074936037.SGD","LU1585245621.USD","BK4534","LU2505996681.GBP","LU0345769128.USD","LU0795875086.SGD","LU0320765646.SGD","LU1718418525.SGD","LU1244550494.USD","LU2430703095.HKD","IE00BGHQF631.EUR","LU2602419157.SGD","LU2592432038.USD","LU2750360641.GBP","LU1066051811.HKD","IE00B4R5TH58.HKD","LU0683600562.USD","LU1066051225.USD","IE00BSNM7G36.USD"],"gpt_icon":0},{"id":"1110568242","title":"加州陪审团裁定强生公司需支付4000万美元，因未警告消费者婴儿爽身粉致癌风险","url":"https://stock-news.laohu8.com/highlight/detail?id=1110568242","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110568242?lang=zh_cn&edition=full","pubTime":"2025-12-13 08:53","pubTimestamp":1765587194,"startTime":"0","endTime":"0","summary":"加州陪审团裁定强生公司因未能有效警告消费者婴儿爽身粉可能的致癌风险，需向原告支付4000万美元的赔偿金。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3B42.SGD","IE00B3PB1722.GBP","LU0345769631.USD","LU2430703095.HKD","IE00BDGV0183.EUR","LU0289739699.SGD","LU0689626769.HKD","BK4592","IE00BSNM7G36.USD","LU2592432038.USD","LU0203347892.USD","LU1506573853.SGD","LU0345769128.USD","LU0234570918.USD","LU1032955483.USD","IE00B1BXHZ80.USD","IE00B3T34201.USD","LU1162221912.USD","IE00BKVL7J92.USD","LU0234572021.USD","BK4585","LU2129689605.HKD","BK4533","IE00BFTCPJ56.SGD","LU0058720904.USD","LU1066053197.SGD","LU1244550577.SGD","LU0345770308.USD","IE0002141913.USD","IE0002270589.USD","LU1023059063.AUD","IE00B4R5TH58.HKD","LU2112291526.USD","LU1059921491.USD","LU0795875086.SGD","LU1066051811.HKD","LU2471134523.USD","LU0432979614.USD","LU1061106388.HKD","LU0070217475.USD","IE00BN8TJ469.HKD","BK4550","LU1244550494.USD","LU2750360641.GBP","LU1894683264.USD","LU0912757837.SGD","IE00BVYPNW00.USD","SG9999002224.SGD","LU1894683348.USD","LU2468319806.SGD","LU1066051498.USD","LU2602419157.SGD","LU1221951046.USD","LU1430594728.SGD","BK4568","LU1674673428.USD","SG9999001440.SGD","IE00BFXG1179.USD","BK4588","LU0114720955.EUR","IE00BGHQF631.EUR","IE00BJJMRZ35.SGD","LU1221951129.SGD","IE00B42XCP33.USD","LU0124676726.USD","IE00BLSP4239.USD","LU2347655156.SGD","LU2471134952.CNY","IE0009355771.USD","LU0098860793.USD","LU0345770993.USD","LU1935042991.SGD","LU0683600562.USD","JNJ","LU1066051225.USD","IE00BBT3K403.USD","IE0034235303.USD","LU0320765646.SGD","LU2129689431.USD","LU1244550221.USD","LU2129689514.USD","LU1732799900.SGD","IE00BZ1G4Q59.USD","BK4534","IE00B2B36J28.USD","LU2430703178.SGD","IE00B19Z3581.USD","LU2089984988.USD","BK4532","LU2471134879.HKD","LU1496350502.SGD","LU2430703251.USD","LU1032466523.USD","LU1280957306.USD","LU1261432733.SGD","LU1778281490.HKD","BK4504","LU2505996681.GBP","LU0985320562.USD","IE00B7SZLL34.SGD","BK4559","LU2471134796.USD","LU1674673691.USD","IE00BLSP4452.SGD","LU0889566641.SGD","IE000M9KFDE8.USD","LU1267930813.SGD","LU1914381329.SGD","LU0787776722.HKD","LU2750360997.AUD","LU0882574055.USD","BK4007","IE00BVYPNV92.GBP","IE00BJT1NW94.SGD","LU0466842654.USD","LU1929549753.HKD","LU1732800096.USD","LU2505996509.AUD","LU1196500208.SGD","LU1074936037.SGD","LU0792757196.USD","LU0122379950.USD","LU1718418525.SGD","LU0203345920.USD","SG9999002232.USD","LU1057294990.SGD","LU0795875169.SGD","BK4581","LU2133065610.SGD","LU1585245621.USD","LU0640476718.USD"],"gpt_icon":0},{"id":"1185432796","title":"FDA批准Niraparib和Abiraterone Acetate联合泼尼松用于BRCA2突变的转移性去势敏感性前列腺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1185432796","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185432796?lang=zh_cn&edition=full","pubTime":"2025-12-13 05:20","pubTimestamp":1765574416,"startTime":"0","endTime":"0","summary":"FDA批准Niraparib和Abiraterone Acetate联合泼尼松用于BRCA2突变的转移性去势敏感性前列腺癌","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0683600562.USD","LU0098860793.USD","LU2089984988.USD","LU0203345920.USD","IE00BN8TJ469.HKD","LU2129689605.HKD","JNJ","LU1066051225.USD","IE00BZ1G4Q59.USD","SG9999002224.SGD","IE000M9KFDE8.USD","BK4585","LU0640476718.USD","BK4533","BK4581","LU1162221912.USD","BK4568","IE00B3PB1722.GBP","IE00BVYPNV92.GBP","BK4534","LU1935042991.SGD","LU0234570918.USD","LU2347655156.SGD","LU2592432038.USD","LU1032466523.USD","IE00BFXG1179.USD","LU1244550494.USD","LU1032955483.USD","IE00BDGV0183.EUR","LU0124676726.USD","LU0345770308.USD","IE00BGHQF631.EUR","LU0795875169.SGD","LU1280957306.USD","LU2602419157.SGD","LU1074936037.SGD","LU1261432733.SGD","LU2505996681.GBP","IE00B3T34201.USD","LU2430703095.HKD","BK4559","IE00B42XCP33.USD","LU2430703251.USD","LU1066051811.HKD","IE00BLSP4239.USD","BK4592","LU1221951046.USD","IE00BKVL7J92.USD","LU0122379950.USD","LU1061106388.HKD","BK4007","LU0882574055.USD","LU1221951129.SGD","LU1732800096.USD","IE00B7SZLL34.SGD","IE0034235303.USD","IE00B19Z3581.USD","LU2750360997.AUD","LU2129689514.USD","LU0795875086.SGD","LU0345769631.USD","BK4504","LU0320765646.SGD","LU1267930813.SGD","LU0912757837.SGD","LU2430703178.SGD","LU0289739699.SGD","LU1430594728.SGD","LU1674673428.USD","LU2112291526.USD","LU0889566641.SGD","BK4550","IE00BSNM7G36.USD","LU0234572021.USD","LU1914381329.SGD","IE00BJJMRZ35.SGD","LU0432979614.USD","SG9999001440.SGD","LU1059921491.USD","IE0002270589.USD","IE00BBT3K403.USD","LU1894683264.USD","IE00BFTCPJ56.SGD","IE00B19Z3B42.SGD","IE00BJT1NW94.SGD","LU0689626769.HKD","IE00B2B36J28.USD","SG9999002232.USD","LU0070217475.USD","LU1244550577.SGD","IE0002141913.USD","LU1244550221.USD","LU1066053197.SGD","LU1066051498.USD","LU1023059063.AUD","LU2468319806.SGD","LU0058720904.USD","LU1894683348.USD","LU1929549753.HKD","LU1585245621.USD","LU1496350502.SGD","LU0792757196.USD","LU0985320562.USD","IE0009355771.USD","LU1196500208.SGD","LU2471134879.HKD","LU2471134796.USD","IE00B4R5TH58.HKD","LU2133065610.SGD","IE00B1BXHZ80.USD","LU1732799900.SGD","LU2471134952.CNY","LU0203347892.USD","BK4588","LU0787776722.HKD","LU2750360641.GBP","LU1674673691.USD","IE00BLSP4452.SGD","LU2129689431.USD","LU1506573853.SGD","LU0466842654.USD","LU0114720955.EUR","BK4532","LU2471134523.USD","LU1718418525.SGD","LU1778281490.HKD","IE00BVYPNW00.USD","LU2505996509.AUD","LU0345769128.USD","LU1057294990.SGD","LU0345770993.USD"],"gpt_icon":0},{"id":"1164632612","title":"欧洲药品管理局推荐扩展Arexvy、Aspaveli、Dovprela、Elucirem、Eylea、Nucala、Recarbrio、Simponi、Uplizna、Vueway的适应症","url":"https://stock-news.laohu8.com/highlight/detail?id=1164632612","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164632612?lang=zh_cn&edition=full","pubTime":"2025-12-12 21:50","pubTimestamp":1765547422,"startTime":"0","endTime":"0","summary":"欧洲药品管理局（Ema）的药物评审委员会（Chmp）推荐扩展以下药物的适应症：Arexvy、Aspaveli、Dovprela、Elucirem、Eylea、Nucala、Recarbrio、Simponi、Uplizna和Vueway。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203345920.USD","MRK","LU2461242641.AUD","LU1035773651.USD","LU0912757837.SGD","IE00BVYPNW00.USD","LU2347655156.SGD","LU1032466523.USD","LU2471134796.USD","IE0034235071.USD","SG9999014542.SGD","IE00B2B36J28.USD","LU1400636574.HKD","LU1015430645.USD","LU0053666078.USD","LU1481600234.SGD","LU1934455194.USD","GSK.UK","LU0265550946.USD","LU0889566641.SGD","LU1196500208.SGD","BK5011","LU1066051811.HKD","LU1228905037.USD","LU1989772840.SGD","BK4534","IE00BQJZX424.USD","LU1917777945.USD","LU0234572021.USD","LU0889565916.HKD","IE0034235303.USD","LU1778281490.HKD","LU0122379950.USD","LU0070302665.USD","LU2125154778.USD","BK4585","LU2471134523.USD","LU2468319806.SGD","LU2602419157.SGD","LU1280957306.USD","LU0985481810.HKD","SG9999013999.USD","LU1023059063.AUD","LU0265550359.USD","LU0234570918.USD","LU0689626769.HKD","LU1093756168.USD","LU1093756325.SGD","LU1674673691.USD","LU2471134879.HKD","SG9999002232.USD","LU1098665638.USD","LU1935042991.SGD","LU1941712264.USD","SG9999014575.USD","LU0106261372.USD","LU1066051225.USD","LU0965509283.SGD","LU1481599808.USD","LU1929549753.HKD","IE00B3PB1722.GBP","LU0320765646.SGD","LU1244550494.USD","IE00B7SZLL34.SGD","LU1914381329.SGD","LU1894683348.USD","LU0321505868.SGD","LU0320765992.SGD","LU0965509010.AUD","LU2023250843.SGD","IE0002270589.USD","LU0683600562.USD","LU1057294990.SGD","LU1974910355.USD","LU0648001328.SGD","LU0823416689.USD","LU1035777561.USD","LU1309081286.SGD","LU2430703095.HKD","LU2505996509.AUD","SG9999001176.USD","SG9999015358.SGD","BK4588","LU1430594728.SGD","IE00B4R5TH58.HKD","LU2237438978.USD","LU2471134952.CNY","LU0985320562.USD","LU2362541513.USD","LU1989771016.USD","LU1487256676.USD","LU1506573853.SGD","LU0238689110.USD","LU1934455863.HKD","LU0211331839.USD","LU0795875169.SGD","LU1201861249.SGD","LU2324357040.USD","LU1116320737.USD","LU1670756490.USD","LU0225771236.USD","LU2129689514.USD","LU2106854487.HKD","BK4559","SG9999001176.SGD","LU0306806265.USD","LU0477156953.USD","LU0124676726.USD","LU1983299246.USD","LU2430703178.SGD","LU0289739699.SGD","IE0002141913.USD","IE00BFTCPJ56.SGD","LU1046248800.SGD","LU1221951129.SGD","LU0109394709.USD","LU0306807586.USD","LU2592432038.USD","LU2360032135.SGD","BK4516","LU0882574055.USD","LU0575583348.USD","IE00B42XCP33.USD","BK4550","LU0006306889.USD","LU1291159041.SGD","BK4007","REGN","LU0345769128.USD","LU0640476718.USD","LU2112291526.USD","LU2129689605.HKD","LU1674673428.USD","SG9999014567.USD","LU1645745479.HKD","IE00B19Z3581.USD","LU2089984988.USD","LU0109981661.USD","BK4568","IE00BZ1G4Q59.USD","IE00BBT3K403.USD","LU0225284248.USD","LU1302929846.USD","LU1585245621.USD","LU0203347892.USD","LU1941712348.USD","LU0823434583.USD","LU2133065610.SGD","LU0795875086.SGD","LU2125154935.USD","LU1571399168.USD","BK4592","LU1732800096.USD","LU0114720955.EUR","JNJ","IE00BJT1NW94.SGD","LU1061106388.HKD","LU1037948897.HKD","IE00B1BXHZ80.USD","IE00BN8TJ469.HKD","LU1074936037.SGD","LU1064927863.SGD","LU0345770308.USD","IE000M9KFDE8.USD","LU0208291251.USD","LU2023250504.SGD","LU2430703251.USD","LU0965508806.USD","LU0345769631.USD","LU0792757196.USD","LU0965509101.SGD","LU2361044865.SGD","LU0432979614.USD","LU2361044949.HKD","IE0009355771.USD","IE00BSNM7G36.USD","LU0320765489.SGD","IE00B3T34201.USD","LU0971552673.USD","LU1699723380.USD","LU0098860793.USD","LU1162221912.USD","LU0130517989.USD","LU0823434740.USD","IE00B19Z3B42.SGD","LU1244550577.SGD","LU1400636491.USD","IE00BFXG1179.USD","LU2505996681.GBP","LU0058720904.USD","IE00BDGV0183.EUR","LU1066051498.USD","LU1267930813.SGD","LU1221951046.USD","LU0971552830.HKD","LU1261432733.SGD","LU2750360641.GBP","IE00BJJMRZ35.SGD","LU1732799900.SGD","LU1244550221.USD","LU1037948541.HKD","BK4504","LU1400636657.SGD","BK4533","LU0321505439.SGD","LU0545562505.USD","LU0345770993.USD","SG9999014559.SGD","BK4139","LU1066053197.SGD","LU0161305163.EUR","BK4532","IE00BKVL7J92.USD","LU0787776722.HKD","LU0980610538.SGD","LU2129689431.USD","LU1989772923.USD","LU2362540622.SGD","IE00BVYPNV92.GBP","LU2362541273.HKD","SG9999001440.SGD","LU0861579265.USD","LU1202635105.USD","LU1116320901.HKD","LU1069347547.HKD","LU1228905540.USD","IE00BLSP4239.USD","LU1934455277.USD","LU2750360997.AUD","LU1718418525.SGD","SGXZ57979304.SGD","LU0466842654.USD","LU1894683264.USD","LU0266013472.USD","LU1059921491.USD","LU2361045086.USD","IE00BWDBJ516.SGD","SG9999002224.SGD","LU0070217475.USD","SG9999015341.SGD","LU1496350502.SGD","IE00BLSP4452.SGD","BK4581","LU0130102774.USD","LU1032955483.USD","IE00BGHQF631.EUR"],"gpt_icon":0},{"id":"2590957484","title":"花旗上调强生目标价至232美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2590957484","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590957484?lang=zh_cn&edition=full","pubTime":"2025-12-12 16:43","pubTimestamp":1765528987,"startTime":"0","endTime":"0","summary":"花旗将强生的目标价从215美元上调至232美元，维持“买入”评级。\n\n美股频道更多独家策划、专家专栏，免费查阅>>\n\r\n 责任编辑：山上","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2025/12/12164354682490.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["JNJ"],"gpt_icon":0},{"id":"2590536267","title":"强生多发性骨髓瘤联合疗法取得“显著”成果","url":"https://stock-news.laohu8.com/highlight/detail?id=2590536267","media":"环球市场播报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590536267?lang=zh_cn&edition=full","pubTime":"2025-12-10 23:50","pubTimestamp":1765381800,"startTime":"0","endTime":"0","summary":"强生（JNJ）周三早盘上涨1.7%，此前有报告称该公司的Tecvayli联合Darzalex相比标准方案将疾病进展或死亡风险降低83%，或支持更早线使用；随着治疗范式演变，Carvykti的合作方传奇生物（LEGN）也受到关注。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-12-10/doc-inhaiuqv0226005.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE00BBT3K403.USD","LU0203347892.USD","BK4585","IE00BGHQF631.EUR","IE00BZ1G4Q59.USD","LU2129689431.USD","LU2129689514.USD","LU2471134523.USD","BK4550","LU2471134879.HKD","LU1778281490.HKD","LU2505996509.AUD","IE000M9KFDE8.USD","LU2471134796.USD","JNJ","LU1032466523.USD","BK4581","BK4532","LU0795875086.SGD","LU1585245621.USD","LU2430703178.SGD","IE00BJJMRZ35.SGD","LU1674673428.USD","LU2133065610.SGD","LU1221951046.USD","LU2089984988.USD","LU0345769631.USD","LU0114720955.EUR","LU1066053197.SGD","IE0034235303.USD","LU2430703095.HKD","LU1732799900.SGD","LU0466842654.USD","LU0098860793.USD","IE0002141913.USD","LU1894683264.USD","LU0234572021.USD","LU1032955483.USD","IE00BLSP4452.SGD","LU0792757196.USD","LU2505996681.GBP","LU0070217475.USD","LU1244550577.SGD","IE00BKVL7J92.USD","LU1430594728.SGD","IE00BSNM7G36.USD","LU1674673691.USD","LU1914381329.SGD","LU1496350502.SGD","SG9999002232.USD"],"gpt_icon":0},{"id":"1192770072","title":"阶段 III Majestec-3 研究的前所未有结果支持 Tecvayli® 联合 Darzalex Faspro® 作为复发/难治性多发性骨髓瘤患者的潜在第二线标准治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1192770072","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192770072?lang=zh_cn&edition=full","pubTime":"2025-12-09 20:47","pubTimestamp":1765284461,"startTime":"0","endTime":"0","summary":"阶段 III Majestec-3 研究的前所未有结果支持 Tecvayli® 联合 Darzalex Faspro® 作为复发/难治性多发性骨髓瘤患者的潜在第二线标准治疗。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0070217475.USD","LU0795875169.SGD","LU0912757837.SGD","LU1032955483.USD","BK4007","BK4588","IE00BLSP4239.USD","LU1267930813.SGD","BK4592","LU2347655156.SGD","LU1057294990.SGD","IE00BBT3K403.USD","LU2430703251.USD","LU0345770993.USD","IE0009355771.USD","LU2471134879.HKD","LU1935042991.SGD","LU1914381329.SGD","LU2471134952.CNY","IE00B3PB1722.GBP","LU2089984988.USD","LU1061106388.HKD","LU2505996509.AUD","LU2468319806.SGD","LU1023059063.AUD","LU0345769631.USD","LU0985320562.USD","IE00B1BXHZ80.USD","LU0098860793.USD","LU0289739699.SGD","IE00BZ1G4Q59.USD","LU1430594728.SGD","LU2430703178.SGD","BK4532","IE00B19Z3581.USD","LU2129689431.USD","LU1674673428.USD","IE00BJT1NW94.SGD","IE00BDGV0183.EUR","JNJ","LU2129689514.USD","LU0889566641.SGD","IE000M9KFDE8.USD","LU0114720955.EUR","IE00BN8TJ469.HKD","LU1674673691.USD","LU0203347892.USD","IE00BLSP4452.SGD","IE00BVYPNV92.GBP","LU0432979614.USD","LU0203345920.USD","IE00BVYPNW00.USD","LU0234570918.USD","SG9999002232.USD","IE00B2B36J28.USD","LU1066053197.SGD","LU1894683348.USD","BK4533","LU0640476718.USD","LU1032466523.USD","LU2129689605.HKD","BK4568","SG9999002224.SGD","LU1732799900.SGD","LU0466842654.USD","LU1221951046.USD","IE00B7SZLL34.SGD","BK4550","LU2133065610.SGD","IE0002270589.USD","IE00BFTCPJ56.SGD","BK4581","LU0882574055.USD","IE00B42XCP33.USD","LU1261432733.SGD","LU1244550221.USD","LU1894683264.USD","IE00BJJMRZ35.SGD","LU1496350502.SGD","IE00BKVL7J92.USD","LU0058720904.USD","LU2471134523.USD","BK4585","LU1280957306.USD","LU0122379950.USD","LU2750360997.AUD","LU0345770308.USD","LU1929549753.HKD","LU1732800096.USD","LU1778281490.HKD","IE00B3T34201.USD","LU1506573853.SGD","LU2112291526.USD","BK4559","SG9999001440.SGD","LU1162221912.USD","IE0034235303.USD","IE00BFXG1179.USD","LU2471134796.USD","LU0792757196.USD","IE0002141913.USD","LU0234572021.USD","LU1066051498.USD","LU1059921491.USD","BK4504","LU1196500208.SGD","LU1244550577.SGD","LU1221951129.SGD","IE00B19Z3B42.SGD","LU1074936037.SGD","LU1585245621.USD","BK4534","LU2505996681.GBP","LU0345769128.USD","LU0795875086.SGD","LU0320765646.SGD","LU1718418525.SGD","LU1244550494.USD","LU2430703095.HKD","IE00BGHQF631.EUR","LU2602419157.SGD","LU2592432038.USD","LU2750360641.GBP","LU1066051811.HKD","IE00B4R5TH58.HKD","LU1066051225.USD","IE00BSNM7G36.USD"],"gpt_icon":0},{"id":"2589385703","title":"礼来(LLY.US)、强生(JNJ.US)与辉瑞(PFE.US)拓展中国市场：旗下创新药物纳入首版商保目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2589385703","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589385703?lang=zh_cn&edition=full","pubTime":"2025-12-08 11:41","pubTimestamp":1765165294,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，礼来、辉瑞和强生在中国首个创新药物目录中占据了一席之地，开辟了新的市场渠道，提高了昂贵尖端疗法的销售前景。这些药品涵盖多种疾病，包括癌症、阿尔茨海默病以及罕见遗传性疾病。随着中国人口老龄化，对癌症、糖尿病、痴呆症等疾病治疗药物的需求日益增长，将这些药物纳入医保体系或可减轻国家医保的负担。BeOne Medicines是唯一一家有两款药物上榜的公司。政府并未立即公布平均折扣幅度。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378669.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["JNJ","LU2129689605.HKD","LU1032955483.USD","LU2417539215.USD","LU1267930730.SGD","LU0203347892.USD","LU1261432733.SGD","LU1868836591.USD","LU0456855351.SGD","LU1221951129.SGD","IE00BKVL7J92.USD","LU0889566641.SGD","LU0122379950.USD","BK4516","IE00B1XK9C88.USD","LU0316494557.USD","LU0471298694.HKD","LU0006306889.USD","LU0820561818.USD","LU1974910355.USD","IE0034235303.USD","LU2265009873.SGD","IE00BVYPNW00.USD","IE0004445015.USD","IE00BKDWB100.SGD","LU1989771016.USD","BK4504","IE00BLSP4452.SGD","LU1244550494.USD","LU2750360641.GBP","LU2063271972.USD","IE00BFTCPJ56.SGD","LU2168564149.EUR","LU0985481810.HKD","LU2106854487.HKD","LU2746668461.USD","LU1064131342.USD","IE00B19Z3B42.SGD","LU2361045086.USD","LU0289739699.SGD","LU0466842654.USD","LU0320765646.SGD","LU1732799900.SGD","LU1430594728.SGD","LU0114720955.EUR","IE00BZ1G4Q59.USD","LU0256863811.USD","IE0009355771.USD","LU2324357040.USD","IE00B775H168.HKD","LU2461242641.AUD","LU1506573853.SGD","LU2133065610.SGD","LU2237443978.SGD","LU1894683264.USD","LU2430703095.HKD","LU0079474960.USD","IE00BDGV0183.EUR","LU1093756168.USD","IE00BVYPNV92.GBP","LU1623119135.USD","SG9999014906.USD","SGXZ51526630.SGD","IE00BFXG1179.USD","BK1161","BK4568","IE0005OL40V9.USD","LU0061475181.USD","LU2112291526.USD","LLY","IE00BKPKM429.USD","LU2168564065.EUR","LU2211815571.USD","LU0320765059.SGD","LU0708995401.HKD","LU2430703178.SGD","LU0353189680.USD","SG9999018865.SGD","IE00BJLML261.HKD","BK4007","IE00BLSP4239.USD","LU0823434740.USD","DRAG","LU0943347566.SGD","LU1069344957.HKD","BK4559","LU1894683348.USD","LU2456880835.USD","LU1718418525.SGD","IE00B1BXHZ80.USD","SG9999013999.USD","LU1267930813.SGD","LU1732800096.USD","LU0345769631.USD","IE00B7SZLL34.SGD","IE00BN29S564.USD","LU2168564222.USD","LU2237438978.USD","IE00BFSS7M15.SGD","LU1366192091.USD","LU0882574055.USD","LU1162221912.USD","LU1868836914.USD","IE00BK4W5M84.HKD","LU0225771236.USD","IE00BJT1NW94.SGD","LU1804176565.USD","LU0058720904.USD","LU1093756325.SGD","LU1496350502.SGD","LU0820561909.HKD","LU1585245621.USD","LU0225284248.USD","IE00B7KXQ091.USD","LU1244550221.USD","BK4581","LU1674673691.USD","LU1712237335.SGD","LU2357305700.SGD","IE00B2B36J28.USD","LU2505996681.GBP","SG9999003800.SGD","SGXZ99366536.SGD","LU2592432038.USD","LU2746668974.SGD","LU0170899867.USD","LU1127390331.HKD","LU0203345920.USD","LU1720051017.SGD","ASHR","BK4532","LU1280957306.USD","LU2471134523.USD","LU0471298777.SGD","LU0912757837.SGD","IE00B3T34201.USD","LU1074936037.SGD","LU1551013425.SGD","LU2360106947.USD","FXI","SG9999002224.SGD","LU2430703251.USD","LU2471134796.USD","CHAU","BK4534","LU0868494617.USD","SG9999001440.SGD","IE00BFSS8Q28.SGD","SG9999018857.SGD","SGXZ81514606.USD","LU0234570918.USD","LU0306806265.USD","GB00BDT5M118.USD","IE00BGHQF631.EUR","SGXZ57979304.SGD","LU0234572021.USD","IE00BK4W5L77.USD","LU0321505439.SGD","LU2236285917.USD","ASHS","PFE","LU1221951046.USD","SGXZ31699556.SGD","LU0096364046.USD","LU0345770308.USD","LU2237443465.HKD","IE0002270589.USD","LU0353189763.USD","BK1574","IE00BJJMRZ35.SGD","LU1323610961.USD","IE00BBT3K403.USD","IE0004445239.USD","SG9999015978.USD","IE00B4R5TH58.HKD","BK4533","LU2168564495.EUR","LU1548497426.USD","LU0354030511.USD","LU1914381329.SGD","LU2505996509.AUD","LU2361044949.HKD","LU2552382058.USD","LU0098860793.USD","IE00BWXC8680.SGD","LU0266013472.USD","LU0640476718.USD","CQQQ","LU0795875169.SGD","LU1868837136.USD","LU2602419157.SGD","SG9999017495.SGD","LU0203202063.USD","LU0320765992.SGD","LU1035775433.USD","LU2237443549.SGD","LU2264538146.SGD","SG9999014914.USD","LU0198837287.USD","KWEB","BK4592","LU1066051811.HKD","LU0256863902.USD","SG9999002232.USD","LU2552382215.SGD","LU1244550577.SGD","LU0354030438.USD","IE000M9KFDE8.USD","CWEB","LU2750360997.AUD","LU2023250504.SGD","LU0689472784.USD","LU1674673428.USD","IE00BSNM7G36.USD","LU0070217475.USD","LU0823416689.USD","SG9999015945.SGD","SG9999015986.USD","LU1988902786.USD","LU2471134879.HKD","LU1929549753.HKD","LU0823434583.USD","IE00B4JS1V06.HKD","LU2491050071.SGD","LU2237443895.HKD","IE00B19Z3581.USD","LU0321505868.SGD","LU1778281490.HKD","LU1883839398.USD","LU2108987350.USD","LU0985320562.USD","LU1023059063.AUD","LU1935042991.SGD","LU1061106388.HKD","SG9999014880.SGD","BK4550","LU0109394709.USD","LU0432979614.USD","LU2129689431.USD","LU0323591593.USD","BK4614","IE00BJJMRX11.SGD","LU1066051225.USD","LU1057294990.SGD","LU2089984988.USD","LU0792757196.USD","LU1059921491.USD","SG9999011175.SGD","LU2087625088.SGD","LU0786609619.USD","LU1066051498.USD","LU1551013342.USD","LU2237443382.USD","LU2491050154.USD","BK4585","LU0385154629.USD","LU1032466523.USD","IE00BJJMRY28.SGD","LU2129689514.USD","LU2237443622.USD","LU0097036916.USD","IE00B42XCP33.USD","BK4588","LU0203201768.USD","LU2468319806.SGD","LU0238689110.USD","LU1917777945.USD","LU0106261372.USD","LU0306807586.USD","MCHI","LU2552382132.HKD","LU1291159041.SGD","LU0795875086.SGD","IE0002141913.USD","SG9999001176.SGD","LU0109391861.USD","LU2168563687.JPY","LU2471134952.CNY","LU0345769128.USD","LU1868837300.USD","LU1983299246.USD","LU1868836757.USD","IE00B3PB1722.GBP","LU0882574139.USD","LU0345770993.USD","BK4599","LU2347655156.SGD","LU1066053197.SGD","SG9999015952.SGD","LU0889565916.HKD","LU1814569148.SGD","LU0094547139.USD","LU2462157665.USD","SG9999014898.SGD","LU0417517546.SGD","LU0672654240.SGD","LU2491049909.HKD","SG9999001176.USD","LU1720051108.HKD","IE00BN8TJ469.HKD","LU1232071149.USD","LU1196500208.SGD","LU2361044865.SGD"],"gpt_icon":1},{"id":"2589039807","title":"2025国谈落地：双管齐下 从“用得上”走向“用得起”","url":"https://stock-news.laohu8.com/highlight/detail?id=2589039807","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589039807?lang=zh_cn&edition=full","pubTime":"2025-12-08 00:09","pubTimestamp":1765123740,"startTime":"0","endTime":"0","summary":"2026年1月1日起，中国医保目录将迎来历史上规模最大的一次创新药扩容。新版医保目录将于2026年1月1日起正式实施。当创新药从“临床可用”迈向“医保可及”，一场深刻的产业变革正在悄然发生。诺华共有2个新产品及4个新适应症成功纳入2025年版国家医保药品目录。此次阿斯利康康可期纳入2025年国家医保目录，助力血液肿瘤患者“活得更长、活得更好”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120807455197953c25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120807455197953c25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1585","BK1574","02171","BK1161","JNJ","02196","BK1587","06978"],"gpt_icon":0},{"id":"2589982216","title":"AI制药，炒作还是革命？权威媒体：调查400位业内人士，发现了行业真相","url":"https://stock-news.laohu8.com/highlight/detail?id=2589982216","media":"智药局","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589982216?lang=zh_cn&edition=full","pubTime":"2025-12-06 18:05","pubTimestamp":1765015548,"startTime":"0","endTime":"0","summary":"近年来，AI制药迅速崛起。在短短几年内，AI已从一个小众技术转变为生物制药议程的固定内容。四分之三的受访者表示，预计人工智能将在2030年前彻底改变药物研发。更不用说数十亿美元授权协议流入了AI制药。制药业的高管和科学家对人工智能的前景最为看好，超过78%的受访者认为AI将在3-5年内变革药物研发。AI变革生物医药，最大的阻碍是什么？这次调研里，对重度使用AI的玩家来说，这一时刻可能已经到来。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251206180930a7277463&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251206180930a7277463&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0058720904.USD","IE00BZ1G4Q59.USD","JNJ","LU1674673428.USD","SG9999002224.SGD","IE00B2B36J28.USD","LU1057294990.SGD","LU1261432733.SGD","IE00BVYPNV92.GBP","LU1023059063.AUD","BK4568","IE00B3T34201.USD","LU2592432038.USD","LU1066051811.HKD","LU2112291526.USD","IE00BFXG1179.USD","LU0985320562.USD","BK4559","SG9999001440.SGD","BK4588","IE00BJT1NW94.SGD","LU2602419157.SGD","LU1244550494.USD","LU0070217475.USD","IE00B4R5TH58.HKD","LU0640476718.USD","IE00BLSP4452.SGD","LU2133065610.SGD","LU1894683264.USD","IE00B19Z3B42.SGD","SG9999002232.USD","IE00BDGV0183.EUR","LU1066053197.SGD","BK4550","IE00BN8TJ469.HKD","LU2430703251.USD","IE0009355771.USD","LU1929549753.HKD","BK4007","LU0912757837.SGD","LU0289739699.SGD","LU1732800096.USD","LU2471134523.USD","IE00B1BXHZ80.USD","AI","LU0432979614.USD","LU1061106388.HKD","LU1506573853.SGD","LU1935042991.SGD","LU1221951129.SGD"],"gpt_icon":0},{"id":"2589822165","title":"2026年1月1日起，强生将迎来重大重组！","url":"https://stock-news.laohu8.com/highlight/detail?id=2589822165","media":"药智医械","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589822165?lang=zh_cn&edition=full","pubTime":"2025-12-06 10:01","pubTimestamp":1764986478,"startTime":"0","endTime":"0","summary":"本次重组对强生内部部门及多个领导层做出相对应的调整。据悉，该重组决定始于2024年初开始向更加去中心化、端到端运营模式转型的基础上作出的，当时，强生已将约3.5万名医疗科技员工转入各业务部门。10月14日，强生公布其2025年第三季度财报时，正式官宣其骨科业务板块的拆分决定，将在未来18至24个月内，将其骨科业务分拆为一家名为DePuy Synthes的独立公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251206112621a726fbcb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251206112621a726fbcb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2468319806.SGD","IE00BLSP4239.USD","LU1496350502.SGD","LU1935042991.SGD","JNJ","IE00BZ1G4Q59.USD","IE00B4R5TH58.HKD","LU0234570918.USD","IE00BLSP4452.SGD","LU1674673691.USD","BK4007","LU2129689514.USD","LU1894683264.USD","LU2505996509.AUD","LU2592432038.USD","LU1244550494.USD","LU1032466523.USD","LU1061106388.HKD","IE00BBT3K403.USD","LU2750360641.GBP","LU1059921491.USD","LU0795875169.SGD","LU1066053197.SGD","LU0320765646.SGD","LU0114720955.EUR","LU2347655156.SGD","BK4532","LU2129689605.HKD","SG9999002224.SGD","LU0640476718.USD","LU0098860793.USD","LU2750360997.AUD","LU0345770308.USD","LU2133065610.SGD","IE0009355771.USD","IE00B3T34201.USD","IE0002141913.USD","IE00B3PB1722.GBP","LU2505996681.GBP","IE00B7SZLL34.SGD","LU2602419157.SGD","BK4504","LU1430594728.SGD","LU0203345920.USD","LU1066051498.USD","LU1732800096.USD","IE00B2B36J28.USD","BK4559","LU1267930813.SGD","IE00B42XCP33.USD"],"gpt_icon":0},{"id":"2588016306","title":"巴克莱上调强生目标价至197美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588016306","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588016306?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:15","pubTimestamp":1764749710,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0912757837.SGD","SG9999002224.SGD","LU1929549753.HKD","LU2347655156.SGD","IE00BBT3K403.USD","BK4504","IE00B19Z3B42.SGD","LU0058720904.USD","IE00BJT1NW94.SGD","LU0345769128.USD","LU2430703095.HKD","IE0034235303.USD","LU0466842654.USD","LU0345769631.USD","LU1032955483.USD","IE0002270589.USD","BK4585","IE00BFXG1179.USD","LU0122379950.USD","LU0640476718.USD","LU0792757196.USD","LU1261432733.SGD","IE00B19Z3581.USD","LU1280957306.USD","LU2089984988.USD","JNJ","BK4592","IE00BKVL7J92.USD","LU2129689514.USD","LU2468319806.SGD","LU0289739699.SGD","LU0795875169.SGD","LU0345770993.USD","LU1732799900.SGD","LU1162221912.USD","LU2471134879.HKD","IE00B4R5TH58.HKD","LU1023059063.AUD","LU2129689605.HKD","IE00BSNM7G36.USD","LU2750360997.AUD","LU1066051225.USD","BK4550","LU1074936037.SGD","LU1196500208.SGD","LU0203345920.USD","BK4559","IE00BVYPNW00.USD","LU1244550221.USD","LU1059921491.USD"],"gpt_icon":0},{"id":"2588408504","title":"阿尔茨海默病研发不易，诺和诺德、强生新药试验接连失败！","url":"https://stock-news.laohu8.com/highlight/detail?id=2588408504","media":"制药网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588408504?lang=zh_cn&edition=full","pubTime":"2025-12-02 11:20","pubTimestamp":1764645651,"startTime":"0","endTime":"0","summary":"近期，阿尔茨海默病疗法的开发就接连遭遇滑铁卢。在同一时期，强生的阿尔茨海默病项目之一也宣布失败。虽然近期多家药企在阿尔茨海默病药物研发方面遭遇滑铁卢，但在众多药企涌入该赛道持续推动创新的背景下，还是有不少药企迎来了好消息。如万邦德、绿叶制药等多家国内药企就相继公布了阿尔茨海默病研究新进展。LY03017拟用于治疗阿尔茨海默病精神病性障碍、帕金森病精神病性障碍、精神分裂症阴性症状。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202112442978aec9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202112442978aec9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0432979614.USD","LU1057294990.SGD","LU1066051498.USD","LU1718418525.SGD","LU2430703095.HKD","IE00BGHQF631.EUR","LU0154236417.USD","IE00BLSP4239.USD","IE0009355771.USD","LU1496350502.SGD","LU0882574055.USD","LU1267930813.SGD","IE0002141913.USD","BK4568","JNJ","LU2471134879.HKD","LU1059921491.USD","LU2089984988.USD","NVO","LU1032466523.USD","BK4581","LU0114720955.EUR","IE00BVYPNV92.GBP","IE0034235303.USD","IE00B19Z3B42.SGD","LU0345769631.USD","BK4585","LU2471134523.USD","LU2750360641.GBP","BK4007","LU0203347892.USD","LU1066051225.USD","LU1061106388.HKD","LU1162221912.USD","LU0234570918.USD","IE00B2B36J28.USD","BK4592","IE00BN8TJ469.HKD","LU1732799900.SGD","LU2112291526.USD","BK4588","LU2129689431.USD","LU1221951129.SGD","LU0122379950.USD","LU0795875086.SGD","IE00BFXG1179.USD","BK4504","LU2133065610.SGD","LU1032955483.USD","BK4534"],"gpt_icon":1},{"id":"2586296706","title":"创新高！华尔街看涨情绪浓厚 强生(JNJ.US)市值首破5000亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586296706","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586296706?lang=zh_cn&edition=full","pubTime":"2025-11-27 07:44","pubTimestamp":1764200661,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周三，强生市值达到 5000 亿美元。周三，这家制药及医疗设备制造商的股价上涨了 0.4%，达到 207.56 美元，首次收于 5000 亿美元上方。强生公司正寄希望于新的药物和收购行动来补充其产品线，并弥补Stelara销量下滑所带来的损失。对于强生公司未来 12 个月的股价预期，市场普遍估计约为 205 美元，这比周三的收盘价略有下降。医药股的涨势主要得益于礼来公司,该公司股价今年已上涨 43%，上周还成为首家市值达到 1 万亿美元的制药公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374209.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0795875169.SGD","IE00BFTCPJ56.SGD","IE00BGHQF631.EUR","IE00B4R5TH58.HKD","LU1023059063.AUD","LU1244550221.USD","LU0345770993.USD","LU1162221912.USD","BK4559","IE00B3PB1722.GBP","LU2347655156.SGD","LU0985320562.USD","LU2129689605.HKD","IE00BBT3K403.USD","LU1674673428.USD","BK4588","LU1778281490.HKD","LU2471134523.USD","LU1732799900.SGD","LU1066051225.USD","LU1935042991.SGD","LU0122379950.USD","BK4504","LU2602419157.SGD","LU2430703178.SGD","LU0466842654.USD","LU1244550494.USD","LU1929549753.HKD","LU1074936037.SGD","IE00BDGV0183.EUR","JNJ","BK4568","IE0002270589.USD","BK4007","IE000M9KFDE8.USD","IE00BSNM7G36.USD","LU1506573853.SGD","LU0234572021.USD","LU0889566641.SGD","LU2430703095.HKD","IE00BFXG1179.USD","BK4581","LU0203345920.USD","LU0203347892.USD","LU0795875086.SGD","IE0034235303.USD","LU1066051498.USD","IE00BLSP4239.USD","LU1894683348.USD","IE00BZ1G4Q59.USD"],"gpt_icon":0},{"id":"2586474490","title":"2025年，药企已达成4起超百亿元收购！","url":"https://stock-news.laohu8.com/highlight/detail?id=2586474490","media":"制药网","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586474490?lang=zh_cn&edition=full","pubTime":"2025-11-25 10:28","pubTimestamp":1764037735,"startTime":"0","endTime":"0","summary":"2025年，全球药企收购活动频发。其中，多家跨国巨头围绕弥补核心产品增长短板、补强细分赛道管线等原因，已展开了多笔超百亿元人民币的收购。默沙东92亿美元收购Cidara Therapeutics11月17日消息，默沙东宣布以92亿美元现金收购Cidara Therapeutics，将其处于3期临床试验的主要资产流感预防药物CD388收入囊中。2024年6月，该药已获美国FDA批准上市，作为维持疗法治疗COPD成人患者。据悉，其此次收购旨在进一步扩大强生在实体瘤及前列腺癌治疗领域的业务版图。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112510331395189b86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112510331395189b86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BN8TJ469.HKD","LU1059921491.USD","CNS","IE00BVYPNV92.GBP","IE00BZ1G4Q59.USD","LU0234570918.USD","LU1061106388.HKD","LU0070217475.USD","LU1935042991.SGD","LU1261432733.SGD","LU1674673691.USD","LU0234572021.USD","LU0320765646.SGD","IE00B2B36J28.USD","LU0795875086.SGD","IE00BBT3K403.USD","LU2129689514.USD","BK4007","LU0345770308.USD","IE00BGHQF631.EUR","LU1585245621.USD","IE00BFXG1179.USD","LU2592432038.USD","BK4581","LU1066051498.USD","LU0345769128.USD","LU0985320562.USD","SG9999002232.USD","LU1074936037.SGD","LU0466842654.USD","IE00BKVL7J92.USD","LU0912757837.SGD","LU0889566641.SGD","LU1280957306.USD","LU0289739699.SGD","BK4585","IE00B3T34201.USD","IE00B7SZLL34.SGD","LU2430703095.HKD","BK4135","LU1244550494.USD","LU2430703178.SGD","SG9999002224.SGD","LU2129689431.USD","IE00B19Z3581.USD","LU1032466523.USD","LU1430594728.SGD","BK4532","LU0058720904.USD","JNJ"],"gpt_icon":0},{"id":"2584347681","title":"强生(JNJ.US)first-in-class新药在国内申报上市 CDE将其纳入拟优先审评","url":"https://stock-news.laohu8.com/highlight/detail?id=2584347681","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584347681?lang=zh_cn&edition=full","pubTime":"2025-11-20 21:22","pubTimestamp":1763644954,"startTime":"0","endTime":"0","summary":"同日，盐酸伊可白滞素片也被 CDE 纳入了拟优先审评，标志其在中国上市进程迈出关键一步。盐酸伊可白滞素片是强生斥资近10亿美元从 Protagonist 引进的 first-in-class 口服多肽药物。今年7月该药在美国申报上市，9月在欧洲申报上市。截至第 24 周，Icotrokinra 的 AE 发生率在数值上低于氘可来昔替尼。据悉，盐酸伊可白滞素片由强生与Protagonist Therapeutics公司联合开发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1371794.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0203345920.USD","LU1066051225.USD","LU0098860793.USD","IE00BVYPNW00.USD","IE00B3PB1722.GBP","LU0320765646.SGD","BK4550","LU1914381329.SGD","IE00B2B36J28.USD","LU2505996681.GBP","LU2112291526.USD","LU1674673428.USD","LU1223082519.USD","IE00B19Z3581.USD","LU1267930813.SGD","LU2430703095.HKD","LU2505996509.AUD","LU1732799900.SGD","LU1244550221.USD","BK4588","IE00BZ1G4Q59.USD","LU1430594728.SGD","LU1585245621.USD","LU0203347892.USD","LU2471134952.CNY","LU2129689431.USD","LU1778281490.HKD","LU0122379950.USD","LU0795875169.SGD","JNJ","LU1074936037.SGD","LU2602419157.SGD","LU1718418525.SGD","LU2430703251.USD","BK4017","SG9999002232.USD","CDE","LU0234570918.USD","LU1674673691.USD","LU1894683264.USD","LU0432979614.USD","BK4559","SG9999002224.SGD","LU1496350502.SGD","IE00BLSP4452.SGD","IE0009355771.USD","LU2430703178.SGD","LU1032955483.USD","LU2592432038.USD","IE00BGHQF631.EUR"],"gpt_icon":0},{"id":"1193397704","title":"FDA给予Daratumumab和Hyaluronidase-Fihj传统批准，用于新诊断的轻链淀粉样变病","url":"https://stock-news.laohu8.com/highlight/detail?id=1193397704","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193397704?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:50","pubTimestamp":1763574634,"startTime":"0","endTime":"0","summary":"FDA给予Daratumumab和Hyaluronidase-Fihj传统批准，用于新诊断的轻链淀粉样变病。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1061106388.HKD","LU1066053197.SGD","IE00BVYPNV92.GBP","IE00B1BXHZ80.USD","IE00BFXG1179.USD","LU2089984988.USD","IE00B19Z3B42.SGD","BK4592","LU1162221912.USD","IE00BSNM7G36.USD","LU1585245621.USD","LU2471134796.USD","BK4581","LU1732800096.USD","LU1244550494.USD","BK4550","BK4588","IE00B19Z3581.USD","LU0203345920.USD","LU0345770308.USD","LU2430703178.SGD","LU1929549753.HKD","LU2471134952.CNY","IE00BBT3K403.USD","JNJ","LU0345769128.USD","IE00B42XCP33.USD","LU1221951046.USD","LU2430703095.HKD","IE0002141913.USD","LU1066051225.USD","LU1074936037.SGD","LU0058720904.USD","LU1057294990.SGD","LU1032955483.USD","LU1496350502.SGD","LU0882574055.USD","BK4007","LU2592432038.USD","LU2347655156.SGD","LU2471134879.HKD","IE00BJT1NW94.SGD","LU1935042991.SGD","IE00B3T34201.USD","LU0985320562.USD","LU2505996509.AUD","LU1267930813.SGD","BK4532","IE00BLSP4239.USD","LU1023059063.AUD","IE00BLSP4452.SGD","BK4568","LU1506573853.SGD","SG9999001440.SGD","IE00BJJMRZ35.SGD","LU1894683264.USD","LU2602419157.SGD","BK4559","IE00BGHQF631.EUR","LU2468319806.SGD","SG9999002232.USD","LU1674673428.USD","LU0345769631.USD","LU0792757196.USD","LU0122379950.USD","LU1261432733.SGD","BK4533","LU0466842654.USD","SG9999002224.SGD","IE00BZ1G4Q59.USD","LU0432979614.USD","LU0912757837.SGD","LU0234572021.USD","LU0070217475.USD","LU0345770993.USD","LU1430594728.SGD","LU0234570918.USD","IE00BVYPNW00.USD","LU2471134523.USD","LU0795875086.SGD","LU1059921491.USD","IE00BN8TJ469.HKD","IE00BFTCPJ56.SGD","LU2505996681.GBP","LU1244550577.SGD","IE00B2B36J28.USD","LU1778281490.HKD","IE00BDGV0183.EUR","LU0640476718.USD","LU0203347892.USD","LU1221951129.SGD","LU1196500208.SGD","LU2133065610.SGD","BK4534","LU1674673691.USD","LU2129689514.USD","IE0009355771.USD","LU0889566641.SGD","LU2430703251.USD","IE00B7SZLL34.SGD","LU0098860793.USD","IE00B4R5TH58.HKD","LU2750360997.AUD","LU1914381329.SGD","IE0034235303.USD","BK4585","LU0795875169.SGD","IE0002270589.USD","LU2750360641.GBP","LU2129689605.HKD","BK4504","LU1718418525.SGD","LU1732799900.SGD","IE000M9KFDE8.USD","IE00BKVL7J92.USD","LU0320765646.SGD","LU1066051811.HKD","LU1066051498.USD","IE00B3PB1722.GBP","LU1280957306.USD","LU0289739699.SGD","LU2112291526.USD","LU1032466523.USD","LU2129689431.USD","LU1894683348.USD","LU0114720955.EUR","LU1244550221.USD"],"gpt_icon":0},{"id":"1173924790","title":"强生表示FDA批准Caplyta作为辅助抑郁症治疗药物","url":"https://stock-news.laohu8.com/highlight/detail?id=1173924790","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173924790?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:58","pubTimestamp":1763571490,"startTime":"0","endTime":"0","summary":"11月6日——强生公司宣布，美国食品药品监督管理局（FDA）已批准Caplyta作为成人主要抑郁障碍的抗抑郁药物的辅助疗法。Caplyta不需要剂量调整，允许患者从有效剂量42毫克开始治疗。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0985320562.USD","IE00BLSP4452.SGD","LU2471134523.USD","LU2505996509.AUD","IE00BVYPNW00.USD","BK4550","SG9999001440.SGD","LU1261432733.SGD","LU2430703251.USD","LU1066051811.HKD","LU0320765646.SGD","LU1585245621.USD","LU1732799900.SGD","IE00BFTCPJ56.SGD","IE0009355771.USD","IE00B3T34201.USD","LU1244550577.SGD","IE000M9KFDE8.USD","IE00BN8TJ469.HKD","BK4559","LU2133065610.SGD","IE00BKVL7J92.USD","LU1032955483.USD","IE00BDGV0183.EUR","IE00BLSP4239.USD","IE00B1BXHZ80.USD","LU0345769128.USD","IE00BSNM7G36.USD","JNJ","BK4007","LU2129689514.USD","LU0792757196.USD","LU1894683264.USD","LU2592432038.USD","LU1032466523.USD","LU1059921491.USD","IE00B19Z3581.USD","IE00BJJMRZ35.SGD","LU0070217475.USD","SG9999002224.SGD","LU0640476718.USD","IE00BVYPNV92.GBP","LU0466842654.USD","LU2112291526.USD","IE00BGHQF631.EUR","LU0345770308.USD","LU0289739699.SGD","IE0002141913.USD","IE00B3PB1722.GBP","LU1221951129.SGD","IE00B7SZLL34.SGD","LU0912757837.SGD","LU2505996681.GBP","LU1196500208.SGD","IE00BFXG1179.USD","BK4533","IE00BJT1NW94.SGD","LU1280957306.USD","LU2468319806.SGD","BK4585","LU2430703095.HKD","LU1935042991.SGD","IE00BZ1G4Q59.USD","IE00B4R5TH58.HKD","LU0234570918.USD","LU0889566641.SGD","LU1929549753.HKD","BK4568","BK4592","LU1778281490.HKD","LU0795875086.SGD","LU1061106388.HKD","IE00BBT3K403.USD","LU0345769631.USD","LU2750360641.GBP","LU0345770993.USD","LU1066053197.SGD","LU0114720955.EUR","IE0002270589.USD","LU2347655156.SGD","BK4532","LU2129689605.HKD","LU1074936037.SGD","BK4588","LU0203347892.USD","BK4534","LU2430703178.SGD","IE0034235303.USD","LU2602419157.SGD","BK4504","LU1732800096.USD","LU0203345920.USD","IE00B2B36J28.USD","LU1430594728.SGD","IE00B19Z3B42.SGD","LU1267930813.SGD","IE00B42XCP33.USD","LU1162221912.USD","LU1718418525.SGD","LU1244550221.USD","LU1496350502.SGD","LU1066051225.USD","LU1506573853.SGD","LU1674673691.USD","LU1023059063.AUD","LU1057294990.SGD","LU2471134952.CNY","LU1244550494.USD","LU1914381329.SGD","LU2089984988.USD","LU2471134796.USD","LU0432979614.USD","LU0234572021.USD","LU2129689431.USD","LU0795875169.SGD","SG9999002232.USD","LU0122379950.USD","LU0098860793.USD","LU0882574055.USD","LU2750360997.AUD","BK4581","LU1221951046.USD","LU2471134879.HKD","LU1674673428.USD","LU1894683348.USD","LU1066051498.USD","LU0058720904.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.jnj.com","stockEarnings":[{"period":"1week","weight":0.0478},{"period":"1month","weight":0.0884},{"period":"3month","weight":0.1883},{"period":"6month","weight":0.3468},{"period":"1year","weight":0.4468},{"period":"ytd","weight":0.463}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"强生公司于1887年在新泽西州注册成立。强生公司及其子公司从事医疗保健领域各种产品的研发、制造和销售。强生公司是一家控股公司，旗下运营公司几乎遍布全球所有国家。公司的主要重点是与人类健康和福祉相关的产品。公司分为两个业务部门：创新医学和医疗技术。","yearOnYearQuotes":[{"month":1,"riseRate":0.533333,"avgChangeRate":0.001572},{"month":2,"riseRate":0.511111,"avgChangeRate":-0.00366},{"month":3,"riseRate":0.6,"avgChangeRate":0.016639},{"month":4,"riseRate":0.630435,"avgChangeRate":0.032381},{"month":5,"riseRate":0.478261,"avgChangeRate":-0.025904},{"month":6,"riseRate":0.5,"avgChangeRate":0.005615},{"month":7,"riseRate":0.608696,"avgChangeRate":0.013965},{"month":8,"riseRate":0.521739,"avgChangeRate":0.005146},{"month":9,"riseRate":0.5,"avgChangeRate":0.003517},{"month":10,"riseRate":0.695652,"avgChangeRate":0.021187},{"month":11,"riseRate":0.608696,"avgChangeRate":0.017686},{"month":12,"riseRate":0.652174,"avgChangeRate":0.012747}],"exchange":"NYSE","name":"强生","nameEN":"Johnson & Johnson"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"强生(JNJ)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供强生(JNJ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"强生,JNJ,强生股票,强生股票老虎,强生股票老虎国际,强生行情,强生股票行情,强生股价,强生股市,强生股票价格,强生股票交易,强生股票购买,强生股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"强生(JNJ)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供强生(JNJ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}